Drug Profile

Bivalent therapeutic human papillomavirus vaccine - Beijing Health Guard Biotechnology

Alternative Names: Bivalent therapeutic HPV vaccine

Latest Information Update: 15 Feb 2024

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Beijing Health Guard Biotechnology
Class Papillomavirus vaccines; RNA vaccines
Mechanism of Action Immunostimulants

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Preclinical Human papillomavirus infections

Most Recent Events

09 Feb 2024 Beijing Health Guard Biotechnology plans to file an IND application for Human papillomavirus infections to NMPA in 2025 (Beijing Health Guard Biotechnology pipeline, February 2024)
09 Feb 2024 Pharmacodynamics data from a preclinical trial in Human papillomavirus infections released by Beijing Health Guard Biotechnology
09 Feb 2024 Beijing Health Guard Biotechnology plans a clinical trial for Human papillomavirus infections (Unspecified route) (Beijing Health Guard Biotechnology pipeline, February 2024)

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com